Navigation Links
Nanoparticle in the Treatment of Glaucoma

Glaucoma is an eye disease that can cause blindness and affects millions of people worldwide. The nanoparticle can safely get past the blood-brain barrier making it an effective non-toxic tool for drug delivery, said Sudipta Seal, an engineering professor with appointments in UCFs Advanced Materials Processing and Analysis Center and the Nanoscience Technology Center.

Seal and his colleagues from North Dakota State University note in the article that while barely 1-3 percent of existing glaucoma medicines penetrate into the eye, earlier experiments with nanoparticles have shown not only high penetration rates but also little patient discomfort. The miniscule size of the nanoparticles makes them less abrasive than some of the complex polymers now used in most eye drops.

Seal and his team created a specialized cerium oxide nanoparticle and bound it with a compound that has been shown to block the activity of an enzyme (hCAII) believed to play a central role in causing glaucoma.

The disease involves abnormally high pressure of the fluid inside the eye, which, if left untreated, can result in damage to the optic nerve and vision loss. High pressure occurs, in part, because of a buildup of carbon dioxide inside the eye, and the compound blocks the enzyme that produces carbon dioxide.

Seal and a team of collaborators including Sanku Mallik, of North Dakota State University, developed the research on using nanoparticles as a delivery mechanism for the compound after supervising a student summer project at UCF. Duke University undergraduate Serge Reshetnikov spent a summer studying nanoscience on UCFs Orlando campus as part of a Research Experience for Undergraduates (REU) project funded by the National Science Foundation. Reshetnikov started looking into the possibilities of using nanoparticles as drug delivery tools. Subsequent research with his advisors led to the specific application for glaucoma.

In their paper on
'"/>




Page: 1 2

Related medicine news :

1. Gene-Nanoparticle Gene Transfer Is Better Than Viral Vector Transfer System
2. Gold Nanoparticles: Agents For Noninvasive Cancer Therapy
3. Alzheimers Can Be Slowed Down By Gold Nanoparticles
4. Gold Nanoparticles Are Good Detectors Biological Toxins
5. Scientists To Study Effect Of Nanoparticles On Liver
6. Nanoparticles and Their Damage to Liver Cells
7. Effect of Nanoparticles on Liver
8. Use of Nanoparticles in Sunscreen under Scrutiny
9. Tiny Sphere Of Nanoparticles Can Fight Cancer
10. Hybrid Nanoparticles for Multimodal Medical Imaging
11. Nanoparticles Used by Researchers to Attack Brain Tumours
Post Your Comments:
(Date:12/6/2009)... information and Treatment site www.sleeping-with-a-sleeping-disorder.com is ... herbal or natural sleep aids from around the ... a good cause. The submissions will be compiled ... ,Encyclopedia, by YOU, to be sold from the ... donate 100% of the proceeds ,from sales of ...
(Date:12/6/2009)... Attorney Joseph W. Belluck of Belluck & Fox, LLP says dangerous ... holiday seasons. , ... New York, NY (PRWEB) December ... holiday season, they should be alert to reports of recalls due ... injury lawyer., , ,“Close to 230,000 children visit hospital emergency rooms ...
(Date:12/5/2009)... There have been significant scientific advances in the field ... a better understanding of how certain diseases progress in ... with the best care. Research presented today at the ... explores optimal induction therapies for managing multiple myeloma, the ...
(Date:12/5/2009)... December 5 The first Football,for Hope Centre ... opened its doors,today (5 December 2009). FIFA President ... Helen Zille, 2010 FIFA World Cup Organising Committee,South ... Association,President Kirsten Nematandani and Executive Mayor of the ...
(Date:12/5/2009)... 5 Leukemia and myeloproliferative disorders are serious ... at the 51st Annual Meeting of the American ... and improved diagnostic methods for patients suffering from ... lymphoblastic leukemia, and myelofibrosis that are based on ...
Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
... relationship of the place of residence to the health of ... consideration of health of the people living in the plains ... 1996 and reviewed after 15 years, especially concerned with coronary ... of two villages in the lowlands and one in the ...
... may lead you to blindness. According to a new research to ... find out a genetic component that may lead to loss of ... blindness due to age, scientists have come up with a gene ... variety of gene that encodes a protein called complement factor H ...
... in developing a computer aided alert program that can predict ... attempts made to prevent the disease before and the current ... researchers are of the opinion that such a prediction may ... hospitalized patients. ,Deep-vein thrombosis or the formation of ...
... Rimonabant (Acomplia) a selective cannabinoid receptor blocker (CB1), can ... with 20 milligrams of rimonabant a day resulted in ... -- a marker of cardiovascularly dangerous visceral fat. It ... of metabolic syndrome in overweight/obese patients. ,The ...
... (“bad” cholesterol) to below 100 milligrams per deciliter by ... safe and results in fewer cardiovascular events. ,The ... 10 milligrams of atorvastatin (Lipitor) a day to get ... a day or lower. Then, half of the patients ...
... conducted in Spain has focused on the increasing incidence ... be associated with an increased risk of cancer in ... has been proven to have disastrous effects on the ... obstetric complications such as extra uterine pregnancy, or pregnancy ...
Other Medicine News:
(Date:12/4/2009)... FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: ... First Amended Plan of Reorganization and related amended Disclosure Statement ... Delaware. ,, A hearing to consider the adequacy ... 2009, with the hearing on the confirmation of the Plan ...
(Date:12/4/2009)... 4 Amber Pharmacy announced today that it received ... (ACHC) for specialized pharmacy services. For nearly 15 years, ... services to meet the unique needs of specialized conditions. ... services to transplant programs. They work with over 170 ...
(Date:12/4/2009)... Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that ... Phase II-b, dose escalation, clinical trial in Switzerland for ... Oxycyte is the Company,s perfluorocarbon (PFC) therapeutic oxygen carrier. ... the outcome of patients with severe TBI. We hope ...
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Amber Pharmacy Earns Accreditation From ACHC 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Meharry Medical College Officer Will Head the National Dental Association 62420 1Meharry Medical College Officer Will Head the National Dental Association 62420 2Meharry Medical College Officer Will Head the National Dental Association 62420 3Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 1Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 2Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 3Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 4Beneath the Short White Coat 3A A Medical Student Reveals All 62414 1Beneath the Short White Coat 3A A Medical Student Reveals All 62414 2
... Delcath Systems, Inc. (Nasdaq: DCTH ) today announced ... Directors. Dr. Contag is a proven corporate executive with extensive ... , (LOGO: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO ) ... Technologies, Inc. in 2006 and served as CEO. Prior to ...
... 17 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: ... Monitoring Board (DSMB) has determined that the current ... ischemic stroke are unlikely,to show benefit. As a ... trials. NTI will obtain and analyze the data ...
Other Medicine Technology:Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2
... test face is the most widely used contrast ... for four (4) rows of sine-wave gratings. At ... meters), these gratings test the spatial frequencies of ... provides a full contrast sensitivity curve, which is ...
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
... involved with healthcare decisions to keep up ... in their field of interest - a ... the volume of evidence increases. Cochrane Reviews ... single source available for continually updated evidence-based ...
... Ergogenic aids, anabolic steroids, running, shoe ... tennis, common sports problems, the female ... athletes, exercise, exercise (treadmill) stress testing ... illness, acclimatization, neuropraxia, overtraining syndrome, management ...
Medicine Products: